Form 4: Boston Scientific CEO Michael Mahoney Reports Changes in Beneficial Ownership

Sentiment:

SEC Form 4 Filing


Michael Mahoney, Chairman, President & CEO of Boston Scientific, reported changes in his beneficial ownership of company stock due to gifts to and from trusts.

Summary

  • On August 30, 2024, Michael F. Mahoney, Chairman, President & CEO of Boston Scientific, reported changes in his beneficial ownership of Boston Scientific common stock.
  • These changes involve gifts of securities to and from The Michael F. Mahoney 2 Year Qualified Annuity Trusts administered by an independent trustee.
  • Specifically, there were gifts of 114,237 shares from the 2023 trust, 95,041 shares from the 2022 trust, and a gift of 176,245 shares to the 2024 trust.
  • Mahoney directly owns 1,673,878 shares of common stock.
  • Mahoney indirectly owns 290,482 shares via trust.
  • Mahoney indirectly owns 385,523 shares via trust.
  • Mahoney indirectly owns 209,278 shares via trust.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing regarding stock ownership, so the sentiment is neutral.

Industry Context

This is a routine filing related to changes in beneficial ownership by a company executive and doesn't necessarily reflect a change in the company's financial health or strategic direction.

Stakeholder Impact

  • The transactions have minimal impact on stakeholders as they are related to personal financial planning of the CEO.

Key Dates

DateDescription
08/30/2024Date of the transactions involving gifts of Boston Scientific common stock.
09/03/2024Date of signature of the report by Susan Thompson, Attorney-in-Fact.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.